Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML Under the IWG 2023 Criteria"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Samuel Urrutia
By
Insights from 2023 ASH Annual Meeting
FEATURING
Samuel Urrutia
Login to view comments.
Click here to Login